Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,343 | 359 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $803.44 | 43 | $0 (2024) |
| UCB, Inc. | $759.97 | 39 | $0 (2024) |
| ABBVIE INC. | $691.12 | 34 | $0 (2024) |
| Amgen Inc. | $525.05 | 25 | $0 (2023) |
| Biogen, Inc. | $488.25 | 30 | $0 (2024) |
| SK Life Science, Inc. | $472.43 | 22 | $0 (2024) |
| PFIZER INC. | $423.98 | 41 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $369.73 | 20 | $0 (2024) |
| Amneal Pharmaceuticals LLC | $296.04 | 17 | $0 (2024) |
| Lundbeck LLC | $227.43 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,893 | 107 | UCB, Inc. ($323.58) |
| 2023 | $1,395 | 79 | Novartis Pharmaceuticals Corporation ($254.16) |
| 2022 | $1,934 | 110 | Novartis Pharmaceuticals Corporation ($228.64) |
| 2021 | $1,121 | 63 | Amgen Inc. ($238.68) |
All Payment Transactions
359 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Neurology | ||||||
| 12/09/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $30.95 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Neuroscience | ||||||
| 11/21/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $2.80 | General |
| Category: PAIN | ||||||
| 11/18/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $0.85 | General |
| Category: Neurology | ||||||
| 11/16/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $9.03 | General |
| Category: Neurology | ||||||
| 11/16/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $5.12 | General |
| Category: Neurology | ||||||
| 11/14/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.32 | General |
| Category: NEUROLOGY | ||||||
| 11/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: PAIN | ||||||
| 11/06/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Neurology | ||||||
| 11/04/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $14.01 | General |
| 11/04/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Central Nervous System | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $29.69 | General |
| Category: Neurology | ||||||
| 10/23/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.38 | General |
| Category: NEUROLOGY | ||||||
| 10/21/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $37.93 | General |
| Category: Neurology | ||||||
| 10/17/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $5.79 | General |
| Category: Neurology | ||||||
| 10/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.52 | General |
| Category: PAIN | ||||||
| 10/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $1.14 | General |
| Category: PAIN | ||||||
| 10/09/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: Neurology | ||||||
| 10/08/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: NEUROLOGY | ||||||
| 10/07/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Rare Disease | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Neurology | ||||||
| 10/01/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 317 | 399 | $35,852 | $19,130 |
| 2022 | 2 | 229 | 319 | $26,012 | $14,999 |
| 2021 | 2 | 205 | 255 | $21,258 | $11,770 |
| 2020 | 3 | 182 | 254 | $16,298 | $7,414 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 166 | 225 | $22,972 | $12,399 | 54.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 122 | 145 | $9,860 | $5,264 | 53.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 18 | $2,036 | $1,044 | 51.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $984.00 | $423.54 | 43.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 105 | 135 | $13,500 | $7,759 | 57.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 124 | 184 | $12,512 | $7,240 | 57.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 79 | 103 | $7,004 | $4,382 | 62.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 49 | 62 | $6,200 | $3,918 | 63.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 36 | 42 | $4,436 | $2,054 | 46.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 41 | 48 | $3,618 | $1,416 | 39.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 154 | 224 | $15,232 | $6,735 | 44.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 13 | 13 | $546.00 | $400.89 | 73.4% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 15 | 17 | $520.00 | $278.12 | 53.5% |
About Michael Justus, PA-C
Michael Justus, PA-C is a Surgical healthcare provider based in Searcy, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2008. The National Provider Identifier (NPI) number assigned to this provider is 1538330220.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Michael Justus, PA-C has received a total of $6,343 in payments from pharmaceutical and medical device companies, with $1,893 received in 2024. These payments were reported across 359 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($6,343).
As a Medicare-enrolled provider, Justus has provided services to 933 Medicare beneficiaries, totaling 1,227 services with total Medicare billing of $53,313. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Surgical
- Location Searcy, AR
- Active Since 03/20/2008
- Last Updated 02/13/2015
- Taxonomy Code 363AS0400X
- Entity Type Individual
- NPI Number 1538330220
Products in Payments
- KESIMPTA (Drug) $674.01
- Briviact (Drug) $536.42
- Aimovig (Biological) $525.05
- NURTEC ODT (Drug) $430.35
- UBRELVY (Drug) $349.82
- RYTARY (Drug) $273.08
- VUMERITY (Drug) $248.29
- VYEPTI (Biological) $227.43
- QULIPTA (Drug) $211.88
- ULTOMIRIS (Biological) $210.78
- BOTOX (Biological) $182.00
- Rystiggo (Drug) $161.24
- EMGALITY (Drug) $143.46
- Soliris (Drug) $125.90
- NOURIANZ (Drug) $116.91
- RADICAVA (Drug) $111.41
- ADUHELM (Biological) $105.08
- MAYZENT (Drug) $98.85
- TYSABRI (Biological) $85.35
- Leqembi (Drug) $83.27
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.